Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Helen C. Adams currently holds 33,000 shares of Immix Biopharma, Inc. (IMMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Helen C. Adams has been a net buyer of IMMX stock. They have purchased $48.0K and sold $0 worth of shares.
Helen C. Adams's most recent insider trade was on Jun 11, 2024, when they sold 33,000 shares at $0.00 per share.
Helen C. Adams serves as Executive at Immix Biopharma, Inc. (IMMX). They have executed 7 insider transactions totaling $48.0K over their tenure at the company.
Helen C. Adams holds the position of Executive at Immix Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Helen C. Adams has shown a buying trading pattern, with $48.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Helen C. Adams was on Sep 12, 2023, when they purchased $38.5K worth of IMMX shares. This transaction involved 13,000 shares at $2.96 per share.
Helen C. Adams currently owns 33,000 shares of Immix Biopharma, Inc. (IMMX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Helen C. Adams's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Helen C. Adams has 7 Form 4 filings on record as an insider at Immix Biopharma, Inc..
Set alerts for Helen C. Adams and 40,000+ other insiders.